LONDON, UK. (October 17, 2017)-Montrium announced that Illingworth Research Group has selected the Montrium eTMF Connect solution to streamline global clinical operations and centralize collaboration with sponsors and sites. Montrium’s cloud capabilities offer a truly unique collaborative environment for emerging growth organizations within the life sciences, enabling partner organizations to connect through one platform. Illingworth Research Group now benefits from a robust and powerful Electronic Trial Master File platform that streamlines the management of critical clinical trial content, providing clinical sites-as well as sponsors-a consistent interface for efficient and effective collaboration. “eTMF Connect changes how our sponsors and partners work together through providing fast, direct access to critical TMF content and data,” said Helen Springford, vice president of strategic development at Illingworth Research. “With eTMF Connect we can now ensure that our clinical projects and trial master files are managed with greater quality and efficiency by allowing our sponsors and trial partners to centrally access and collaborate on TMF content in real-time. Contract Research Organizations like Illingworth Research Group are under increasing pressure from sponsors to control clinical trial timelines and minimize costs-all while maintaining quality. By selecting eTMF Connect, a cloud-based electronic trial master file solution, Montrium was not only able to deliver a powerful tool to empower better clinical trials but also supported rapid implementation, allowing Illingworth and their partners to realize the benefits of eTMF Connect much faster than traditional enterprise systems. “Illingworth joins a long list of leading life sciences organizations who are centralizing clinical operations and increasing their clinical trial efficiency with eTMF Connect,” said Oliver Pearce, Commercialization Manager at Montrium. “Over the past 12 months, Montrium has seen incredible user growth with our cloud-based eTMF Connect product as we continue to deploy dynamic, powerful, and intuitive content management solutions at a fraction of the time and cost of traditional enterprise systems.” Montrium’s eTMF Connect solution is part of Montrium Connect, a cloud-based regulated-content management platform which includes a suite of applications designed to empower life sciences organizations to delivery safer treatments to patients, faster. Montrium Connect applications support clinical, regulatory, and quality teams as they unify their content management and data across the enterprise. To learn more about the Montrium Connect platform and the powerful collection of applications, please visit www.monrium.com/connect
About Illingworth Research Group: Illingworth Research is a well-established UK based full-service Clinical Research Organization (CRO) with a specialist home-care research nursing solution for clinical trials at home, school or in the workplace. They have expertise in project management, monitoring, regulatory submissions and full-service capability in addition to specialist medical photography services and research nursing provision both on-site and in patient homes and regularly acts as EU Legal Representative for US Sponsors. About Montrium: Montrium is a global leader in cloud-based document & quality management solutions and GxP consulting services for the Life Sciences. Operating in the Life Sciences for over 12 years, Montrium has been successfully helping organizations implement and maintain technology to improve their business processes and increase compliance. Montrium currently serves over 8000 users in more than 20 countries. For more information on the products and services Montrium provides, please visit: www.montrium.com. Montrium Media Contact Oliver Pearce Commercialization Manager +1 514 223 9153 opearce@montrium.com Additional Information For more on eTMF Connect, visit: Montrium.com/eTMFConnect Stay updated on the latest Montrim news on LinkedIn: linkedin.com/company/Montrium Follow @Montrium on Twitter: twitter.com/montrium Like Montrium on Facebook: facebook.com/Montrium
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Fast Tracks Johnson & Johnson’s Nipocalimab for Fetal Neonatal Alloimmune Thrombocytopenia
March 27th 2024Johnson & Johnson is moving forward with a pair of Phase III trials of nipocalimab to reduce the risk of fetal neonatal alloimmune thrombocytopenia in alloimmunized pregnant patients.